Coumel tachycardia in children.

BACKGROUND: Coumel tachycardia is an infrequent form of supraventricular tachycardia (SVT) that usually occurs in infants and children. It is a tachycardia mediated by an accessory pathway with retrograde slow conduction that explains the classic ECG pattern with long RP' interval and negative P waves in leads II, III, and aVF. In this study, we describe the clinical course and management of Coumel tachycardia in children. CASE REPORT: We conducted a retrospective review of five consecutive pediatric patients, mean age 11 ± 3 years (range 6 to 14). The first episode of SVT was at a mean age of 10.4 ± 4.8 years (range 2 to 14) with a mean evolution of 7.4 ± 9.4 months (range 1 to 24). Pharmacological therapy was unsuccessful despite the combination of antiarrhythmic drugs. The tachycardia was incessant with a density > 85% by 24-hour Holter monitoring; one patient developed tachycardia-induced cardiomyopathy. All children underwent successful radiofrequency catheter ablation, mean 5 ± 3 applications (range 1 to 8) with a single session and with no complications. After a mean follow-up of 24 ± 16 months, all patients were asymptomatic and recurrence-free without antiarrhythmic treatment. CONCLUSIONS: Coumel tachycardia is clinically persistent and usually refractory to antiarrhythmic treatment with substantial risk of tachycardia-mediated cardiomyopathy. Catheter ablation is effective and safe in children; thus, it should be indicated promptly and based on individual selection.

INTRODUCCIÓN: La taquicardia de Coumel es una forma poco frecuente de taquicardia supraventricular que suele presentarse en lactantes. Es una taquicardia mediada por una vía accesoria de conducción lenta retrógrada que explica el patrón ECG clásico con intervalo RP' largo y ondas P negativas en las derivaciones II, III y aVF. En este trabajo se describe el curso clínico y el manejo de la taquicardia de Coumel en niños. CASO CLÍNICO: Se llevó a cabo una revisión retrospectiva de cinco pacientes pediátricos consecutivos, con una media de edad de 11 ± 3 años (intervalos 6 a 14). El primer episodio de taquicardia 10.4 ± 4.8 años con evolución de 7.4 ± 9.4 meses. El tratamiento farmacológico fue ineficaz a pesar de la combinación de antiarrítmicos. La taquicardia era incesante con una densidad > 85% por Holter-24h; un paciente desarrolló miocardiopatía inducida por taquicardia. Todos los niños fueron sometidos a ablación con catéter y radiofrecuencia con éxito, y un promedio de 5 ± 3 aplicaciones en una sola sesión y sin complicaciones. Después de un seguimiento de 24 ± 16 meses, todos los pacientes fueron asintomáticos y libres de recurrencia sin tratamiento antiarrítmico. CONCLUSIONES: La taquicardia de Coumel es clínicamente persistente y generalmente refractaria al tratamiento antiarrítmico con un riesgo sustancial de miocardiopatía mediada por taquicardia. La ablación con catéter es eficaz y segura en niños, por lo que debe indicarse de forma temprana y en lactantes de una selección individual.

Coumel tachycardia in children / Taquicardia de Coumel en niños

Abstract Background: Coumel tachycardia is an infrequent form of supraventricular tachycardia (SVT) that usually occurs in infants and children. It is a tachycardia mediated by an accessory pathway with retrograde slow conduction that explains the classic ECG pattern with long RP' interval and negative P waves in leads II, III, and aVF. In this study, we describe the clinical course and management of Coumel tachycardia in children. Case report: We conducted a retrospective review of five consecutive pediatric patients, mean age 11 ± 3 years (range 6 to 14). The first episode of SVT was at a mean age of 10.4 ± 4.8 years (range 2 to 14) with a mean evolution of 7.4 ± 9.4 months (range 1 to 24). Pharmacological therapy was unsuccessful despite the combination of antiarrhythmic drugs. The tachycardia was incessant with a density > 85% by 24-hour Holter monitoring; one patient developed tachycardia-induced cardiomyopathy. All children underwent successful radiofrequency catheter ablation, mean 5 ± 3 applications (range 1 to 8) with a single session and with no complications. After a mean follow-up of 24 ± 16 months, all patients were asymptomatic and recurrence-free without antiarrhythmic treatment. Conclusions: Coumel tachycardia is clinically persistent and usually refractory to antiarrhythmic treatment with substantial risk of tachycardia-mediated cardiomyopathy. Catheter ablation is effective and safe in children; thus, it should be indicated promptly and based on individual selection.

Resumen Introducción: La taquicardia de Coumel es una forma poco frecuente de taquicardia supraventricular que suele presentarse en lactantes. Es una taquicardia mediada por una vía accesoria de conducción lenta retrógrada que explica el patrón ECG clásico con intervalo RP' largo y ondas P negativas en las derivaciones II, III y aVF. En este trabajo se describe el curso clínico y el manejo de la taquicardia de Coumel en niños. Caso clínico: Se llevó a cabo una revisión retrospectiva de cinco pacientes pediátricos consecutivos, con una media de edad de 11 ± 3 años (intervalos 6 a 14). El primer episodio de taquicardia 10.4 ± 4.8 años con evolución de 7.4 ± 9.4 meses. El tratamiento farmacológico fue ineficaz a pesar de la combinación de antiarrítmicos. La taquicardia era incesante con una densidad > 85% por Holter-24h; un paciente desarrolló miocardiopatía inducida por taquicardia. Todos los niños fueron sometidos a ablación con catéter y radiofrecuencia con éxito, y un promedio de 5 ± 3 aplicaciones en una sola sesión y sin complicaciones. Después de un seguimiento de 24 ± 16 meses, todos los pacientes fueron asintomáticos y libres de recurrencia sin tratamiento antiarrítmico. Conclusiones: La taquicardia de Coumel es clínicamente persistente y generalmente refractaria al tratamiento antiarrítmico con un riesgo sustancial de miocardiopatía mediada por taquicardia. La ablación con catéter es eficaz y segura en niños, por lo que debe indicarse de forma temprana y en lactantes de una selección individual.

Cardiomiopatía inducida por taquicardia en niños y adolescentes / Tachycardia-induced cardiomyopathy in children and adolescents

Introducción. La cardiomiopatía dilatada idiopática es la forma más común de cardiomiopatía en niños; sin embargo, ocasionalmente son identificadas causas potencialmente reversibles. Entre estas existe un grupo de pacientes con manifestaciones de insuficiencia cardiaca y taquicardia persistente que representan una forma de cardiomiopatía no familiar adquirida conocida como cardiomiopatía inducida por taquicardia o taquicardiomiopatía, que es reversible con el tratamiento efectivo de la taquicardia. Estos pacientes pueden ser mal diagnosticados y tratados de forma inapropiada. El diagnóstico frecuentemente es tardío, por lo que debe sospecharse en pacientes con insuficiencia cardiaca y taquicardia persistente sin causa aparente. Casos clínicos. Se describen seis casos de pacientes pediátricos de 6 a 16 años de edad (media 12 ± 4 años) que se presentaron con manifestaciones clínicas de insuficiencia cardiaca. Tuvieron seguimiento por una forma de cardiomiopatía dilatada en los que se documentaron diferentes mecanismos de taquiarritmia persistente como la causa. El tratamiento apropiado -mediante ablación con catéter- condujo a la recuperación de la función ventricular. Conclusiones. Es importante el reconocimiento de la cardiomiopatía inducida por taquiarritmia en pediatría. También es necesario un diagnóstico oportuno así como un tratamiento eficaz, ya que la cardiomiopatía inducida por taquicardia es una causa reversible de insuficiencia cardiaca.

Background. Idiopathic dilated cardiomyopathy is the most common form of cardiomyopathy in children; however, potentially reversible causes may occasionally be identified. Among these a group of patients with symptoms of congestive heart failure and persistent tachycardia representing a form of nonfamilial acquired cardiomyopathy known as tachycardia-induced cardiomyopathy or tachycardiomyopathy. This is a reversible condition with effective treatment of tachycardia. These patients may be misdiagnosed, potentially leading to inappropriate treatment. Diagnosis is often late and always should be suspected in patients with congestive heart failure and unexplained persistent tachycardia. Case reports. We describe six pediatric patients (mean age 12 ±4 years old, range 6-16 years). Patients presented with clinical manifestations of heart failure followed by dilated cardiomyopathy. Different mechanisms of persistent tachycardia were documented as the cause and total recovery was achieved of ventricular function after successful treatment of tachycardia by catheter ablation. Conclusions. The recognition of tachyarrhythmia-induced cardiomyopathy in pediatric patients is important. Opportune diagnosis and effective treatment are necessary because tachycardia-induced cardiomyopathy is a reversible cause of heart failure.

Estenosis valvular aórtica congénita. Actualización del tratamiento / Congenital aortic valve stenosis. Current treatment

OBJECTIVE: Congenital aortic valve stenosis is a common lesion, with an approximate incidence of 5 to 7% of all cardiac malformations and occupies the first place among left heart obstructions. In recent years, many modalities of treatment have been developed. Fetal interventions has evolved in one extreme of life, on the other hand, percutaneous aortic valve replacement is now available for aged adults. In children and adolescents, percutaneous aortic valve valvuloplasty is now more effective with new techniques. The Ross procedure is the first choice treatment in children and young adults with hipoplastic aortic annulus. Considerable medical information has evolved and expanded from these techniques. A review of the indications, optimal timing, and outcomes of these procedures is pertinent.

[Congenital aortic valve stenosis. Current treatment]. / Estenosis valvular aórtica congénita. Actualización del tratamiento.

OBJECTIVE: Congenital aortic valve stenosis is a common lesion, with an approximate incidence of 5 to 7% of all cardiac malformations and occupies the first place among left heart obstructions. In recent years, many modalities of treatment have been developed. Fetal interventions has evolved in one extreme of life, on the other hand, percutaneous aortic valve replacement is now available for aged adults. In children and adolescents, percutaneous aortic valve valvuloplasty is now more effective with new techniques. The Ross procedure is the first choice treatment in children and young adults with hipoplastic aortic annulus. Considerable medical information has evolved and expanded from these techniques. A review of the indications, optimal timing, and outcomes of these procedures is pertinent.

[Cardiac rhabdomyoma surgically treated with success. Review of literature]. / Rabdomioma cardiaco tratado quirúrgicamente con exito y revisión de la literatura.

The primary cardiac tumors are inusual, the incidence varies in all the ages between 0.005 to 0.05%. In pediatrics patients the incidence is 0.27%. The more frequent tumors during the childhood are the cardiac rhabdomyomas. These tumors are considered benigns. The clinical expression is wide, in the most the cases, the patients are asymptomatic and are detected by murmurs. In the prenatal age are manifested by arrhythmias or hydrops fetalis. The neonates and children may be show cardiac arrhythmias, low cardiac index and sudden cardiac death. The association with tuberous sclerosis had been reported in 81%. We present a neonate with cardiac rhabdomyoma diagnosed in the newborn period when he was asymptomatic, however in the follow-up he developed cardiac failure by obstruction in the out flow tract of the right ventricle. He underwent open cardiac surgery to resect the obstruction. Five months after surgery, the patient remain asymptomatic.

Rabdomioma cardiaco tratado quirúrgicamente con éxito y revisión de la literatura / Cardiac rhabdomyoma surgically treated with success. Review of literature

Los tumores cardiacos primarios son raros, con incidencia variable en todas las edades del 0.005 al 0.05%. En pacientes pediátricos, la incidencia es del 0.27%. Los tumores más frecuentes durante la infancia son los rabdomiomas cardiacos, considerados como benignos. Aunque la expresión clínica es amplia, en la mayoría de los casos son asintomáticos y se detectan por la presencia de soplos. En la etapa prenatal se manifiestan con arritmias o hydrops fetalis. En algunos neonatos y lactantes se encuentran arritmias, datos de bajo gasto cardíaco o muerte súbita. La asociación con esclerosis tuberosa se ha observado hasta en un 81%. Se presenta el caso de paciente masculino neonato, con diagnóstico de rabdomioma cardiaco que inicialmente estaba asintomático, sin embargo en el seguimiento requirió de tratamiento quirúrgico a los 5 meses de edad, por datos de insuficiencia cardiaca secundaria a obstrucción del tracto de salida del ventrículo derecho. A 5 meses de la cirugía, el paciente está asintomático.

The primary cardiac tumors are inusual, the incidence varies in all the ages between 0.005 to 0.05%. In pediatrics patients the incidence is 0.27%. The more frequent tumors during the childhood are the cardiac rhabdomyomas. These tumors are considered benigns. The clinical expression is wide, in the most the cases, the patients are asymptomatic and are detected by murmurs. In the prenatal age are manifested by arrhythmias or hydrops fetalis. The neonates and children may be show cardiac arrhythmias, low cardiac index and sudden cardiac death. The association with tuberous sclerosis had been reported in 81%.We presenta neonate with cardiac rhabdomyoma diagnosed in the newborn period when he was asymptomatic, however in the follow-up he developed cardiac failure by obstruction in the out flow tract of the right ventricle. He underwent open cardiac surgery to resect the obstruction. Five months after surgery, the patient remain asymptomatic.